参考文献/References:
[1]Oster G,Lamerato L,Glass AG,et al.Natural history of skeletal related events in patients with breast,lung,or prostate cancer and metastases to bone:a 15-year study in two large US health systems[J].Support Care Cancer,2013,21(12):3279-3286.
[2]双卫兵,邓欣.前列腺癌骨转移的治疗[J].现代泌尿生殖肿瘤杂志,2015,7(6):373-376.
[3]Ferlay J,Shin HR,Bray FD,et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer,2010,127(12):2893-2917.
[4]罗晓辉,刘建舟,门群利,等.唑来膦酸联合内分泌治疗前列腺癌骨转移的临床观察[J].中国现代医学杂志,2015,25(36):90-92.
[5]孟谊,王立峰.前列腺癌骨转移相关疼痛的治疗[J].癌症进展,2013,11(6):531-537.
[6]李倩倩,崔艳芬,储彩婷,等.MRI与骨扫描诊断前列腺癌骨转移的比较[J].国际医学放射学杂志,2015,38(1):5-8.
[7]林玮斌,苏晓萍,张燕美.唑来膦酸联合核素89Sr治疗晚期前列腺癌骨转移性疼痛的观察及护理[J].医学信息,2015,28(31):114.
[8]Lin CP,Lin WY,Lin FS,et al.Efficacy of intrathecal drug delivery system for refractory cancer pain patients:a single tertiary medical center experience[J].J Formos Med Assoc,2012,111(5):253-257.
[9]Lux EA,Heine J.Home care treatment of cancer pain patients with patient-controlled analgesia(PCA)[J].Schmerz,2011,25(6):663-667.
[10]王承承,孙晓玲,吴长利.前列腺癌的治疗研究进展[J].天津医药,2014,42(l0):1051-1053.
[11]邴建勇,张自刚,李秀凤,等.前列腺癌内分泌治疗后患者长期生存情况及相关预后因素探析[J].中国继续医学教育,2017,9(9):121-122.
[12]姜良真,崔喆,王宝龙.间歇性内分泌治疗晚期前列腺癌的临床可行性及有效性[J].中国性科学,2017,26(6):5-7.
[13]祝培,阮建中.晚期前列腺癌间歇与持续性内分泌治疗的临床疗效分析[J].中国实用医药,2016,11(13):198-199.
[14]陈齐峰,印荣,俞弘颀,等.内分泌治疗联合唑来膦酸对前列腺癌骨转移疗效观察[J].中外医学研究,2016,14(15):12-14.
[15]刘军.唑来膦酸联合全雄激素阻断治疗前列腺癌骨转移的疗效观察[J].医学信息,2013,26(1):180.
[16]祁德安,鲍业忠,史怿,等.唑来膦酸联合酮康唑及强的松治疗晚期去势抵抗性前列腺癌骨转移[J].中外医学研究,2015,13(16):18-20.
[17]张广伟,朱朝阳,李铁强.唑来膦酸治疗晚期前列腺癌骨转移性疼痛疗效分析[J].中国实用医刊,2013,40(20):32-33.
[18]李军,张强,郭斌,等.全雄激素阻断联合复方苦参注射液疗法治疗前列腺癌骨转移的疗效观察[J].甘肃医药,2015,34(8):585-587.
[19]吴玉华,易舒婧,王华中,等.自拟温肾壮阳活血汤治疗前列腺癌骨转移疼痛临床观察[J].广西中医药大学学报,2014,17(4):22-23.
[20]黄和涛,温忠霖.蜂针配合中药治疗前列腺癌骨转移一则[J].中国民间疗法,2014,22(4):59.
[21]何静春,李峰,赵丽娟.人参单体皂苷Rh2与顺铂联合应用诱导小鼠前列腺癌凋亡[J].中国老年学杂志,2014,34(6):1555-1557.
[22]尹怀福,修有成,赵维明,等.人参皂甙Rg3对前列腺癌细胞的作用研究[J].现代医学,2016,44(1):1-6.
[23]李云龙,王勇,王伟录,等.老年前列腺癌骨转移患者的焦虑和抑郁调查及心理干预[J].现代医药卫生,2013,29(21):3223-3224.
[24]高会华,韩萍,李晓红.前列腺癌骨转移疼痛患者的观察及护理体会[J].中国继续医学教育,2015，7(12):246-247.
相似文献/References:
[1]袁长翮.超声引导下经直肠前列腺穿刺诊断前列腺癌的价值研究[J].医学信息,2018,31(04):156.[doi:10.3969/j.issn.1006-1959.2018.04.058]
YUAN Chang-he.The Value of Ultrasound Guided Transrectal Prostate Puncture in the Diagnosis of Prostate Cancer[J].Journal of Medical Information,2018,31(06):156.[doi:10.3969/j.issn.1006-1959.2018.04.058]
[2]李 科.骨形态发生蛋白4与乳腺癌骨转移的相关性研究[J].医学信息,2018,31(13):17.[doi:10.3969/j.issn.1006-1959.2018.13.005]
LI Ke.Relationship between Bone Morphogenetic Protein 4 and Bone Metastasis in Breast Cancer[J].Journal of Medical Information,2018,31(06):17.[doi:10.3969/j.issn.1006-1959.2018.13.005]
[3]胡春燕,吴天天,王 殊,等.前列腺癌患者自我感受负担及其影响因素研究[J].医学信息,2018,31(13):173.[doi:10.3969/j.issn.1006-1959.2018.13.054]
HU Chun-yan,WU Tian-tian,WANG Shu,et al.Study on Self-perceived Burden and its Influencing Factors in Patients with Prostate Cancer[J].Journal of Medical Information,2018,31(06):173.[doi:10.3969/j.issn.1006-1959.2018.13.054]
[4]缪继东.盐酸吗啡缓释片联合低剂量阿米替林治疗中重度癌性骨痛的疗效观察[J].医学信息,2018,31(21):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
MIAO Ji-dong.Effects of Morphine Hydrochloride Sustained-release Tablets Combined with Low Dose Amitriptyline in the Treatment of Moderate and Severe Cancer Bone Pain[J].Journal of Medical Information,2018,31(06):147.[doi:10.3969/j.issn.1006-1959.2018.21.042]
[5]曹志彬,王元天,杨伟忠,等.前列腺健康指数在前列腺癌早期诊断中的价值[J].医学信息,2018,31(23):29.[doi:10.3969/j.issn.1006-1959.2018.23.009]
CAO Zhi-bin,WANG Yuan-tian,YANG Wei-zhong,et al.The Value of Prostate Health Index in Early Diagnosis of Prostate Cancer[J].Journal of Medical Information,2018,31(06):29.[doi:10.3969/j.issn.1006-1959.2018.23.009]
[6]卜易莹,韩东兴,刘邦令,等.血清miR-145表达与乳腺癌患者的相关性分析[J].医学信息,2019,32(07):5.[doi:10.3969/j.issn.1006-1959.2019.07.002]
BU Yi-ying,HAN Dong-xing,LIU Bang-ling,et al.Correlation Analysis between Serum miR-145 Expression and Breast Cancer Patients[J].Journal of Medical Information,2019,32(06):5.[doi:10.3969/j.issn.1006-1959.2019.07.002]
[7]张 莹,谢 静.前列腺癌预后标志的研究[J].医学信息,2019,32(09):7.[doi:10.3969/j.issn.1006-1959.2019.09.003]
ZHANG Ying,XIE Jing.Prognostic Markers of Prostate Cancer[J].Journal of Medical Information,2019,32(06):7.[doi:10.3969/j.issn.1006-1959.2019.09.003]
[8]袁也晴,张学齐,汪青蓉,等.KIF14在前列腺癌细胞中的表达及作用[J].医学信息,2019,32(09):68.[doi:10.3969/j.issn.1006-1959.2019.09.022]
YUAN Ye-qing,ZHANG Xue-qi,WANG Qing-rong,et al.Expression and Role of KIF14 in Prostate Cancer Cells[J].Journal of Medical Information,2019,32(06):68.[doi:10.3969/j.issn.1006-1959.2019.09.022]
[9]胡嘉莉,华 琳.miRNA-mRNA双重表达谱在前列腺癌分子调控机制中的作用[J].医学信息,2022,35(16):18.[doi:10.3969/j.issn.1006-1959.2022.16.004]
HU Jia-li,HUA Lin.Role of miRNA-mRNA Dual Expression Profile in Molecular Regulation of Prostate Cancer[J].Journal of Medical Information,2022,35(06):18.[doi:10.3969/j.issn.1006-1959.2022.16.004]
[10]王 乾,孙 宾,李殷南,等.尿液中肌氨酸、PCA3mRNA在前列腺癌
早期诊断中的应用[J].医学信息,2019,32(14):175.[doi:10.3969/j.issn.1006-1959.2019.14.059]
WANG Qian,SUN Bin,LI Yin-nan,et al.Application of Urinary Sarcosine and PCA3mRNA in Early Diagnosis of Prostate Cancer[J].Journal of Medical Information,2019,32(06):175.[doi:10.3969/j.issn.1006-1959.2019.14.059]
[11]王永祥,赵兴华,许长宝,等.初诊前列腺癌骨转移的危险因素分析及预测模型建立[J].医学信息,2023,36(11):16.[doi:10.3969/j.issn.1006-1959.2023.11.003]
WANG Yong-xiang,ZHAO Xing-hua,XU Chang-bao,et al.Risk Factors Analysis and Prediction Model Establishment of Bone Metastasis in Newly Diagnosed Prostate Cancer[J].Journal of Medical Information,2023,36(06):16.[doi:10.3969/j.issn.1006-1959.2023.11.003]